UPADACITINIB | N218347 | ABBVIE INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2026-06-17 | Active | — | |
| D. Del. | 2026-06-11 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| RE47221 | Aug 16, 2033 | — | Yes | — | — | — |
| 8962629 | Jan 15, 2031 | — | Yes | — | — | |
| 9951080 | Oct 17, 2036 | — | Yes | — | — | — |
| 10981923 | Oct 17, 2036 | — | Yes | — | — | — |
| 11186584 | Oct 17, 2036 | — | Yes | — | — | — |
| 11661425 | Oct 17, 2036 | — | Yes | — | — | — |
| 11680069 | Oct 17, 2036 | — | Yes | — | — | — |
| 11718627 | Oct 17, 2036 | — | Yes | — | — | — |
| 11773105 | Oct 17, 2036 | — | Yes | — | — | — |
| 12110298 | Oct 17, 2036 | — | Yes | — | — | — |
| 12365689 | Oct 17, 2036 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NP | Apr 26, 2027 | < 1 year |
| ODE-481 | Apr 26, 2031 | Active |